A drug derived from olive oil has shown promising results in slowing down the progression of the deadly brain cancer glioblastoma. A recent trial conducted by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research involving 54 patients with recurrent glioblastoma and other advanced solid tumors revealed that a drug made from oleic acid, a component naturally found in olive oil, had a significant impact. Results indicated that 24% of the patients with glioblastoma responded well to the treatment, with one experiencing an exceptional response lasting over three years. The drug, known as 2-OHOA, disrupts abnormal growth signals in cancer cells, potentially halting the disease’s advancement. Glioblastoma affects 3,200 individuals in the UK annually and has a grim prognosis, making this breakthrough a beacon of hope for patients battling this aggressive form of brain cancer.
Olive Oil Derivative Shows Promise in Glioblastoma Treatment Study
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
